|
nasdaq:fmi
|
1324997
|
Apr 21st, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 20th, 2024 11:27PM
|
Apr 20th, 2024 11:27PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 20th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 19th, 2024 11:25PM
|
Apr 20th, 2024 05:00PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 19th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 18th, 2024 11:32PM
|
Apr 18th, 2024 11:32PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 18th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 17th, 2024 11:40PM
|
Apr 18th, 2024 06:20PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 17th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 16th, 2024 11:22PM
|
Apr 17th, 2024 02:45PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 16th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 15th, 2024 11:18PM
|
Apr 16th, 2024 11:01AM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 15th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 14th, 2024 11:14PM
|
Apr 15th, 2024 04:42PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 14th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1847
|
Open
|
|
Apr 13th, 2024 11:03PM
|
Apr 13th, 2024 11:03PM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 13th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1849
|
Open
|
|
Apr 12th, 2024 10:54PM
|
Apr 13th, 2024 11:28AM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:fmi
|
1324997
|
Apr 12th, 2024 12:00AM
|
Foundation Medicine
|
75K
|
1849
|
Open
|
|
Apr 11th, 2024 10:59PM
|
Apr 12th, 2024 08:24AM
|
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
Open
|
molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
|
Open
|
400 Summer St
|
Boston
|
Massachusetts
|
US
|
02210
|
|
Foundation Medicine
|
Health Care
|
Pharmaceuticals & Biotechnology
|